Randomised phase II study comparing topotecan/carboplatin administration for 5 versus 3 days in the treatment of extensive-stage small-cell lung cancer.
暂无分享,去创建一个
C. Schade-Brittinger | U. Seifart | C. Mueller | R. Lorenz | M. Wolf | K. Hans | J. Dethling | G. Koschel | T. Fink | H. Schroeder